Literature DB >> 28597623

Impact of a stewardship program on bacteraemia in adult inpatients.

E Merino, E Caro, J R Ramos1, V Boix, A Gimeno, J C Rodríguez, G Riera, P Más, J Sanchéz-Paya, S Reus, D Torrús, J Portilla.   

Abstract

OBJECTIVE: Bloodstream infections (BSIs) are associated with considerable morbidity and mortality among inpatients. The aim of this study was to evaluate the impact of a stewardship program on clinical and antimicrobial therapy-related outcomes in patients with bacteraemia.
METHODS: Single-centre, before-and-after quasi-experimental study in adult inpatients. Over 1 January 2013 to 31 June 2013 all patients aged 18 years or older with a bacteraemia (interven-tion group, N=200) were compared to a historical cohort (1 Janu-ary 2012 to 31 December 2012) (control group, N=200).
RESULTS: Following blood culture results and adjusting for potential confounders, the stewardship program was associated with more changes to antibiotic regimens (adjusted odds ratio [ORa]: 4.6, 95% CI 2.9, 7.4), more adjustments to antimicrobial therapy (ORa: 2.4, 95% CI 1.5, 3.8), and better source control in the first five days (ORa 1.6, 95% CI: 1.0, 2.7). In the subgroup that initially received inappropriate empiric treatment (n=138), the intervention was associated with more antibiotic changes (OR: 3.9, 95% CI: 1.8, 8.5) and a better choice of definitive antimicrobial therapy (OR 2.3 95% CI: 1.2, 4.6). There were also more antibiotic changes in the subgroups with both Gram-negative (OR: 2.8, 95% CI: 1.6, 4.9; n=217) and Gram-positive (OR: 4.6, 95% CI: 1.8, 9.9; n=135) bacteraemia among those receiving the intervention, while the Gram-positive subgroup also received more appropriate definitive antimicrobial therapy (OR: 3.9, 95% CI: 1.8, 8.8).
CONCLUSIONS: The stewardship program improved treatment of patients with bacteraemia and appropriateness of therapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28597623

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


  4 in total

1.  Impact of Sepsis Flow Chip, a novelty fast microbiology method, in the treatment of bacteremia caused by Gram-negative bacilli.

Authors:  E Merino; A Gimeno; M Alcalde; J Coy; V Boix; C Molina-Pardines; M P Ventero; A Galiana; E Caro; J C Rodríguez
Journal:  Rev Esp Quimioter       Date:  2021-03-23       Impact factor: 1.553

2.  Etiology of bloodstream infections at a population level during 2013-2017 in the Autonomous Community of Valencia, Spain.

Authors:  L Ruiz-Azcona; M Santibañez; A Gimeno; F J Roig; H Vanaclocha; M P Ventero; V Boix; J Sánchez-Payá; J Portilla-Sogorb; E Merino; J C Rodríguez
Journal:  Rev Esp Quimioter       Date:  2020-04-29       Impact factor: 1.553

3.  [Strategies for improving the antibiotic treatment prescription in the Emergency Department].

Authors:  E Orviz; P Jerez-Fernández; M Suarez-Robles; C Ramos-Rey; I Armenteros; M Fernández-Revaldería; J González Del Castillo
Journal:  Rev Esp Quimioter       Date:  2020-01-14       Impact factor: 1.553

4.  Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study.

Authors:  Jorge Alba Fernandez; Jose Luis Del Pozo; Jose Leiva; Mirian Fernandez-Alonso; Irene Aquerreta; Azucena Aldaz; Andres Blanco; Jose Ramón Yuste
Journal:  Antibiotics (Basel)       Date:  2022-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.